Lyme arthritis and post-Lyme disease syndrome

Current Opinion in Rheumatology

Volumn 14, Issue 4, 2002, Pages 383-387

  Weinstein, Arthur ^a   Britchkov, Michael ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CEFTRIAXONE; DOXYCYCLINE; GAMMA INTERFERON; HLA DR ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LYME DISEASE VACCINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

ANTIBODY RESPONSE; ARTHRALGIA; ARTHRITIS; AUTOIMMUNITY; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FIBROMYALGIA; HUMAN; IMMUNOBLOTTING; INCIDENCE; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REACTIVE ARTHRITIS; REVIEW; SEROLOGY; ADULT; CHILD; FEMALE; IMMUNOLOGY; INFECTIOUS ARTHRITIS; ISOLATION AND PURIFICATION; PATHOLOGY; SYNDROME;

ADULT; ANTIBIOTICS; ARTHRITIS, INFECTIOUS; BORRELIA BURGDORFERI; CHILD; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; PREGNANCY; SUPPORT, U.S. GOV'T, P.H.S.; SYNDROME; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0035985835     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200207000-00008     Document Type: Review

References (41)

1. Lyme disease
2. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis
3. Practical guidelines for the treatment of Lyme disease
4. Racial difference in reported Lyme disease incidence
5. Lyme disease in children in southeastern Connecticut
6. Lyme arthritis in children and adolescents: Outcome 12 months after initiation of antibiotic therapy
7. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
8. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease
9. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccination against Lyme disease in healthy children and adolescents: Randomized controlled trial
10. Arthritis after Lyme disease vaccine: Selected epidemiologic features based on follow-up evaluation of vaccine adverse event reporting system (VAERS) reports
11. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi
12. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanism of pathogenesis in Lyme arthritis before and after antibiotic treatment
13. Membrane-type matrix metalloproteinase and cell surface-associated activation cascades for matrix metalloproteinases
14. Arthritis following recombinant outer surface protein A vaccination for Lyme disease
15. Gestational attenuation of Lyme arthritis is mediated by progesteron and IL-4
16. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease
17. Evaluation of study patients with Lyme disease, 10-20-year follow-up
18. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis
19. Comparison of reculture and PCR for the detection of Borrelia burgdorferi in cell and tissue cultures after antibiotic treatment
20. Detection of bacterial DNA in serial synovial samples obtained during antibiotic treatment from patients with septic arthritis
21. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles
22. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis
23. Immune responses to Borrelia burgdorferi in patients with reactive arthritis
24. Bacteria-triggered reactive arthritis. Implications for antibacterial treatment
25. The Lyme spirochete: Another cause of Reiter's syndrome?
26. Chalmydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis
27. Intra-articular co-infection by Borrelia burgdorferi and Chalmydia trachomatic
28. False-positive results of PCR testing for Lyme disease
29. Death from inappropriate therapy for Lyme disease
30. Synovial fluid-polymerase chain reaction detection of pathogens: What does it really mean?
31. Brief report: Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis
32. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis
33. Lyme disease: An infectious and postinfectious syndrome
34. Clinical and neurocognitive features of post Lyme syndrome
35. Musculoskeletal and neurological outcomes in patients with previously treated Lyme disease
36. Long-term outcomes of persons with Lyme disease
37. Psychological states and neuropsychological performances in chronic Lyme disease
38. A controlled study of cognitive deficits in children with chronic Lyme disease
39. Detection of Borrelial burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease
40. Tetracycline therapy for chronic Lyme disease
41. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease